Ganoderic Acids Alleviate Neuroinflammation by Targeting Myeloid Differentiation Factor 2 for Ischemic Stroke Therapy.

Ganoderma lucidum

OncologyImmune supportCognition & nervesMetabolic health

SpeciesReishi, Lingzhi

JournalExploration (Beijing, China)

Year2026

Metadata-grounded summary

Article summary

Metadata-grounded summary: This research article indexes research on Ganoderma lucidum in Exploration (Beijing, China) in 2026. MycoData maps the paper to oncology, immune support, cognition & nerves, metabolic health based on its title, species context, article metadata, and study classification.

Citation

Ma A, Zhu Y, Ying Y, Wang S, Zhang J, Feng N, et al. (2026). Ganoderic Acids Alleviate Neuroinflammation by Targeting Myeloid Differentiation Factor 2 for Ischemic Stroke Therapy. Exploration (Beijing, China) https://doi.org/10.1002/EXP.20240147 PMID: 41810066

Open citation